Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/m L in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Works matching IS 14642662 AND DT 2014 AND VI 15 AND IP 1
Results: 12
1
2
Lymphoma and Epstein− Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
3
CYP2B6 -G516T genotype influences plasma efavirenz concentration in a Hong Kong population, allowing potential individualization of therapy.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 63, doi. 10.1111/hiv.12076
- By:
- Publication type:
- Article
4
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 50, doi. 10.1111/hiv.12047
- By:
- Publication type:
- Article
5
Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/m L in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 57, doi. 10.1111/hiv.12071
- By:
- Publication type:
- Article
6
Comparison of transient elastography ( FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/ HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 30, doi. 10.1111/hiv.12082
- By:
- Publication type:
- Article
7
Corrigendum.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 64, doi. 10.1111/hiv.12053
- Publication type:
- Article
8
Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 13, doi. 10.1111/hiv.12075
- By:
- Publication type:
- Article
9
The CD4: CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 40, doi. 10.1111/hiv.12081
- By:
- Publication type:
- Article
10
HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence?
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 1, doi. 10.1111/hiv.12092
- By:
- Publication type:
- Article
11
A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 3, doi. 10.1111/hiv.12074
- By:
- Publication type:
- Article
12
Lymphoma and Epstein− Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 23, doi. 10.1111/hiv.12077
- By:
- Publication type:
- Article